Cyclic-di-GMP

CAT: 0804-HY-107780Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-107780Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Cyclic-di-GMP is a STING agonist and a bacterial second messenger that coordinates different aspects of bacterial growth and behavior, including motility, virulence, biofilm formation, and cell cycle progression. Cyclic-di-GMP has anti-cancer cell proliferation activity and also induces elevated CD4 receptor expression and cell cycle arrest. Cyclic-di-GMP can be used in cancer research[1][2][3][4].
CAS Number
[61093-23-0]
Product Name Alternative
C-di-GMP; cyclic diguanylate; 5GP-5GP
UNSPSC
12352005
Target
Endogenous Metabolite; STING
Type
Natural Products
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Cyclic-di-GMP.html
Purity
98.18
Solubility
H2O : ≥ 25 mg/mL
Smiles
O[C@@H]([C@H](N1C=NC2=C1N=C(N)NC2=O)O3)[C@H](OP(O)(OC[C@@H]4[C@H]([C@H]([C@H](N5C=NC6=C5N=C(N)NC6=O)O4)O)O7)=O)[C@H]3COP7(O)=O
Molecular Formula
C20H24N10O14P2
Molecular Weight
690.41
References & Citations
[1]Karaolis DK, et al. 3',5'-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation. Biochem Biophys Res Commun. 2005 Apr 1;329 (1) :40-5. |[2]Steinberger O, et al. Elevated expression of the CD4 receptor and cell cycle arrest are induced in Jurkat cells by treatment with the novel cyclic dinucleotide 3',5'-cyclic diguanylic acid. FEBS Lett. 1999 Feb 5;444 (1) :125-9. |[3]Wang Z, et al. STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice. Cancer Immunol Immunother. 2015 Aug;64 (8) :1057-66. |[4]Jenal U, et al. Cyclic di-GMP: second messenger extraordinaire. Nat Rev Microbiol. 2017 May;15 (5) :271-284.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Citation 01
Gut Microbes. 2022 Jan-Dec;14 (1) :2119055.|Int J Biol Macromol. 2024 Sep 14:135660.|Mbio. 2021 Oct 26;12 (5) :e0119221.|Clin Transl Med. 2024 Aug;14 (8) :e1744.|NPJ Biofilms Microbiomes. 2024 Jun 20;10 (1) :51.|J Transl Med. 2025 Mar 4;23 (1) :271.|Nucleic Acids Res. 2025 Oct 28;53 (20) :gkaf1069.

Related Products

CatalogName
HY-113469-01Cyclic GMP
HY-113469R-01Cyclic GMP (Standard)
HY-113469B-01Cyclic GMP (TBAOH)
HY-113469A-01Cyclic GMP (sodium)
HY-W767865Cyclic GMP (sodium) -13C5
HY-113469ARCyclic GMP (sodium) (Standard)
HY-W654000Cyclic GMP-13C,15N2
HY-15794GNemorubicin (GMP)
HY-N0737AG-01Harmine (GMP)
HY-N0083GBetulin (GMP)

Alternative Products

CatalogName
NU-951lcyclic-di-GMP
B7839-1Cyclic di-GMP
M34900-01Cyclic-di-GMP disodium
A19725-100Cyclic-di-GMP 100mg
MBS5814697Cyclic-di-GMP diammonium
MBS5806908Cyclic-di-GMP sodium
A19725-1Cyclic-di-GMP 1mg
A19725-10Cyclic-di-GMP 10mg
A19725-25Cyclic-di-GMP 25mg
462326Cyclic di-GMP sodium

Popular Products